Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: manfredhasler who wrote (14616)	9/16/2000 5:51:37 PM
From: Robert K.	Read Replies (1) \| Respond to of 17367

Manfred, it sure looks like protein c to me also.... what does lilly think of protein c? I will tell you. They think protein c will work in sepsis. What they WONT tell you is that they think their protein c is SAFER and WORKS BETTER with bpi. Imagine that> a drug company that wont tell the press what they think may be best. Hmmmmmmm. >http://www.patents.ibm.com/details?pn=WO00023101A1

To: manfredhasler who wrote (14616)	9/16/2000 6:50:27 PM
From: Bluegreen	Read Replies (1) \| Respond to of 17367

So Manfred, can we count on you to help get Neuprex to kids that contract Meningococcemia?

To: manfredhasler who wrote (14616)	9/16/2000 7:09:57 PM
From: Bluegreen	Read Replies (1) \| Respond to of 17367

Manfred, you have to admit Dr. Girior is a real HERO in bringing in a 70% reduction in severe amputations. Let's all get behind Dr. Girior and help the kids with Meningococcemia. 70% reduction in severe amputations.....now that is a MIRACLE medication for kids with Meningococcemia. Imagine what it can do if given IMMEDIATELY with antibiotics!!!!!

To: manfredhasler who wrote (14616)	9/16/2000 8:16:16 PM
From: Cacaito	Read Replies (1) \| Respond to of 17367

Manfred, there was no problem with the design, the recruitment of patients in the high mortality category became a logistics nightmare, mainly cause they could not keep expending money. The company did the best, get as much money during the time data was hidden (no problem for me, I sold a little loss at the time, then I wrongly believe baxter involvement as sign of good data, till the fda proved that wrong). The good doctor Goldstein is just doing the usual show after this type of results, only the proxoma group sees that as "The coming fight for the kids" and dare to see it as a based for an investment.